FDA Used ‘Critically Flawed’ Risk-Benefit Analysis to ‘Justify’ COVID Vaccines for Children • Children's Health Defense

The FDA on Oct. 29, 2021, granted EUA of Pfizer’s COVID-19 vaccine for children 5 to 11 years of age.

FDA Used ‘Critically Flawed’ Risk-Benefit Analysis to ‘Justify’ COVID Vaccines for Children

The U.S. Food and Drug Administration relied on a critically flawed risk-benefit assessment to authorize emergency use of Pfizer’s COVID-19 vaccine for children 5-11 years of age.